High-Purity Solutions for Global Healthcare
RRH Pharma supports global partners in the development, sourcing, and supply of high-value innovator and orphan drugs designed to address rare diseases and critical therapeutic needs.
These specialized therapies represent the forefront of modern medicine, offering life-changing solutions for conditions with limited or no existing treatments. Through strong partnerships with research-driven organizations and regulatory experts, we ensure access to advanced, compliant, and globally aligned pharmaceutical solutions.
| Sr.No | Product | Dosage | Strength | Therapeutic Category |
|---|---|---|---|---|
| 1 | Valsartan | Tablets | 40, 80, 160, 320 mg | Antihypertensive |
| 2 | Furosemide | Tablets | 20, 40, 80 mg | Diuretic & Antihypertensive |
| 3 | Nitazoxanide | Tablets | 500 mg | Antiprotozoal |
| 4 | Trientine Dihydrochloride | Capsules | 250, 300 mg | Wilson's Disease |
| 5 | Sugammadex Sodium | Injection | Eq. 200 mg/2ml, 500 mg/5ml Base | NMJ Reversal |
| 6 | Clozapine | Tablets | 25, 50, 100, 200 mg | Antipsychotic |
| 7 | Vigabatrin | Tablets | 500 mg | Antiepileptic |
| 8 | Tolvaptan (Jynarc) | Tablets | 15, 30, 45, 60, 90 mg | ADPKD |
| 9 | Bilastine | Tablets | 20 mg | Antiallergic |
| 10 | Eltrombopag Olamine | Tablets | Eq. 12.5, 25, 50, 75 mg Acid | Thrombocytopenia |
| 11 | Nirmatrelvir + Ritonavir | Tablets | 150 + 100 mg | Covid Antiviral |
| 12 | Nitisinone | Capsules | 2, 5, 10, 20 mg | Hereditary Tyrosinemia |
Disclaimer : Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Availability may be restricted to certain markets or countries.
Delivering comprehensive pharmaceutical solutions through innovation, compliance, and global expertise.
Access to innovator and orphan drug molecules through reliable global sourcing networks.
End-to-end support for regulatory submissions, documentation, and compliance processes.
Strategic collaboration with research partners for scale-up and commercialization.
Tailored formulation and product development solutions based on client requirements.
Adherence to region-specific regulations and orphan drug compliance standards.
Strong export capabilities ensuring reliable supply across international markets.